US Patent Issued to IBSA INSTITUT BIOCHIMIQUE on May 26 for "Use of a vegetal extract from Salvia haenkei as an active agent in the treatment of a musculoskeletal disorder" (Swiss Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,336, issued on May 26, was assigned to IBSA INSTITUT BIOCHIMIQUE SA (Lugano, Switzerland).

"Use of a vegetal extract from Salvia haenkei as an active agent in the treatment of a musculoskeletal disorder" was invented by Andrea Maria Giori (Lugano, Switzerland) and Andrea Alimonti (Lugano, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of Salvia haenkei extract as an active agent in the treatment of musculoskeletal disorders, being able to offer a significant contribution in slowing, relieving, reducing and/or preventing alterations and damages of the musculoskeletal tissues. Furthermore, the presen...